Most decisions to reject or roll out drugs on NHS backed by poor evidence, study suggests
Two thirds of decisions to reject or roll out drugs on the NHS are backed by poor clinical evidence, a study suggests.
Source: yahoo.com
Stay updated with breaking news from Clinical Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two thirds of decisions to reject or roll out drugs on the NHS are backed by poor clinical evidence, a study suggests.
The demand for pharmacies to play a larger role in the health care ecosystem will not dissipate anytime soon.
Provider of UpToDate, Lexicomp, Emmi, and Medi-Span ranks in the top two out of 20 vendors ...
The potential implications around the broader use of AI raise many questions, given the power of this new technology.
Leanna Petherick is sharing the story of her 17-year-old daughter's death when the paramedics failed to arrive fast enough to save her.